Novel peptide conjugates of modified oligonucleotides for inhibition of bacterial RNase P

7Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Novel alternatives to traditional antibiotics are now of great demand for the successful treatment of microbial infections. Here, we present the engineering and properties of new oligonucleotide inhibitors of RNase P, an essential bacterial enzyme. The series of 2’-O-methyl RNA (2’-OMe-RNA) and phosphoryl guanidine oligonucleotides were targeted to the substrate-binding region of M1 RNA subunit of the RNase P. Uniformly modified 2’-OMe RNA and selectively modified phosphoryl guanidine oligonucleotides possessed good stability in biological media and effectively inhibited RNase P. Their conjugates with transporting peptides were shown to penetrate bacterial cells (Escherichia coli and Acinetobacter baumannii) and inhibit bacterial growth.

Cite

CITATION STYLE

APA

Novopashina, D., Vorobyeva, M., Nazarov, A., Davydova, A., Danilin, N., Koroleva, L., … Venyaminova, A. (2019). Novel peptide conjugates of modified oligonucleotides for inhibition of bacterial RNase P. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00813

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free